EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC-ND 4.0

Is it time to reconsider universal severe acute respiratory syndrome coronavirus 2 polymerase chain reaction screening for asymptomatic potential nonlung solid organ transplant donors?

Yoichiro Natori, Shweta Anjan, Jonathan Hand

American Journal of Transplantation · 2024

DOI: 10.1016/j.ajt.2024.01.021 ↗

Kurz gefasst

Leserbrief in der Zeitschrift American Journal of Transplantation, 2024. Verfasst von Yoichiro Natori und 2 weiteren Autor:innen. Beteiligte Einrichtung: Miami Transplant Institute, Jackson Health System, Miami, Florida, USA; Department of Medicine, Division of Infectious Disease, University of Miami M…. Hauptthemen laut MEDLINE: COVID-19, Organ Transplantation, SARS-CoV-2, Tissue Donors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the beginning of the Coronavirus disease 2019 (COVID-19) pandemic, most of the organ donors have been routinely tested for COVID-19, even though there was no policy requiring Organ Procurement Organizations (OPOs) to test non-lung donors. Bronchoalveolar lavage testing for potential lung donors was implemented after three donor derived infections in lung transplant recipients were reported 1 Notice of OPTN Policy and Data Collection Changes. https://optn.transplant.hrsa.gov/media/4242/covid_19_er_policy-notice-december-2020.pdf. Google Scholar . Over the past three years, the United Network for Organ Sharing ad hoc Donor Transmission Advisory Committee (DTAC) has monitored and investigated possible COVID-19 donor to recipient transmission. Thus far, there have been no proven or probable transmission to non-lung transplant recipients. This finding is consistent with previously reported DTAC data suggesting rare (1 of 28 recipients of positive donors) transmission of other respiratory viruses to non-lung recipients, while 9/9 transmission occurred in lung recipients 2 Kaul D.R. Vece G. Blumberg E. et al. Ten years of donor-derived disease: A report of the disease transmission advisory committee. Am J Transplant. 2021; 21: 689-702https://doi.org/10.1111/ajt.16178 Abstract Full Text Full Text PDF PubMed Scopus (58) Google Scholar . Given the novel nature of SARS-CoV-2 and its peculiar, non-respiratory complications and sequalae, screening all donors in the early pandemic was prudent. With a growing understanding of the safety of transplanting non-lung SARS-CoV-2 positive donors, the utility of universal screening should be questioned. With universal testing of donors for HTLV-1/2, we must consider the potential harm of unnecessary testing that may lead to non-use of organs and increase in waitlist mortality. Additionally, the short and long-term recipient outcomes with use of SARS-CoV-2 PCR positive donors are comparable to negative donors 3 Dhand A. Gass A. John D. et al. Long-term and Short-term Outcomes of Solid Organ Transplantation From Donors With a Positive SARS-CoV-2 Test. Transplantation. Aug 1 2022; 106: e384-e385https://doi.org/10.1097/TP.0000000000004196 Crossref Scopus (7) Google Scholar . However, Madan et. al. reported that heart transplant candidates may have worse outcomes when using donors with positive COVID-19 PCR, even this finding that has not yet been explained and should require additional data as this study has some methodological limitations 4 Madan S. Chan M.A.G. Saeed O. et al. Early Outcomes of Adult Heart Transplantation From COVID-19 Infected Donors. J Am Coll Cardiol. Jun 20 2023; 81: 2344-2357https://doi.org/10.1016/j.jacc.2023.04.022 Crossref Scopus (9) Google Scholar , thus, it might be reasonable to obtain COVID-19 testing for special circumstances, including heart donors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Organ TransplantationSARS-CoV-2Tissue DonorsHumansTissue and Organ ProcurementMass ScreeningCOVID-19 Nucleic Acid TestingPolymerase Chain ReactionDonor Selection

Stichwörter der Autor:innen

SARS-CoV-2adverse eventssolid organ transplantvaccination

Autor:innen und Institutionen

  • Miami Transplant Institute, Jackson Health System, Miami, Florida, USA; Department of Medicine, Division of Infectious Disease, University of Miami Miller School of Medicine Miami, Florida, USA. Electronic address: yxn1…
  • Miami Transplant Institute, Jackson Health System, Miami, Florida, USA; Department of Medicine, Division of Infectious Disease, University of Miami Miller School of Medicine Miami, Florida, USA.
  • Ochsner Health, New Orleans, Louisiana, USA; Department of Medicine, Division of Infectious Disease, University of Queensland School of Meidcine, New Orleansm Louisiana, USA.

Zitieren

APA

Natori, Y., Anjan, S., & Hand, J. (2024). Is it time to reconsider universal severe acute respiratory syndrome coronavirus 2 polymerase chain reaction screening for asymptomatic potential nonlung solid organ transplant donors?. American Journal of Transplantation. https://doi.org/10.1016/j.ajt.2024.01.021

Vancouver

Natori Y, Anjan S, Hand J. Is it time to reconsider universal severe acute respiratory syndrome coronavirus 2 polymerase chain reaction screening for asymptomatic potential nonlung solid organ transplant donors?. American Journal of Transplantation. 2024. doi:10.1016/j.ajt.2024.01.021

BibTeX
@article{Natori2024,
  author = {Natori, Yoichiro and Anjan, Shweta and Hand, Jonathan},
  title = {Is it time to reconsider universal severe acute respiratory syndrome coronavirus 2 polymerase chain reaction screening for asymptomatic potential nonlung solid organ transplant donors?},
  journal = {American Journal of Transplantation},
  year = {2024},
  doi = {10.1016/j.ajt.2024.01.021}
}
Kostenlos starten →